COVID-19: Patents are not adequate incentives for vaccine research
Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings

COVID-19: Patents are not adequate incentives for vaccine research

Charlotte Kilpatrick
March 17, 2020
corona-sucks.png

Pharma in-house attorneys and private counsel explore different reward schemes for vaccine research including vouchers and government prize money

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login

Topics

European UnionInternationalIP StrategyUnited StatesNewsPatentsNorth AmericaEurope
kilpatrick-charlotte-300px.png
Charlotte Kilpatrick
Reporter Managing IP
Contact
Charlotte reports on patent-related issues. She often covers the European market, focusing on developments including FRAND, licensing and trade secrets. She is particularly interested in how new technologies affect IP challenges in the pharmaceutical industry.
more from across site and ros bottom lb

More from across our site

Employer with magnifying glass exploring application papers
Counsel mull due diligence strategies after NPE slammed in court
Sources debate the implications of an opinion by Delaware’s chief judge Colm Connolly that lambasted the NPE IP Edge
Rani Mehta, December 08, 2023
CellectDelaysCOVER.jpg
Firms advise client caution amid USPTO examination delays
Five partners reveal how delays in examining trademark applications are affecting their advice to clients and how they pitch new work
Rani Mehta, December 08, 2023
close-up-of-nokia-headquarters-in-espoo-finland_0 (1).jpg
This week on MIP: Chinese FRAND ruling, Getty v Stability AI
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
Sukanya Sarkar, December 08, 2023
BehindtheCaseQuinnEManual2.jpg
Behind the case: how Quinn Emanuel secured a Texas win for Samsung
Partners at Quinn Emanuel explain how walkie-talkie and real-estate analogies helped them win over a jury at the Eastern District of Texas
Rani Mehta, December 07, 2023
HHQ Photo.png
'Frontline' advice: HHQ eyes untapped market with emerging tech practice
The heads of Malaysian firm HHQ’s new technology practice group say they can be frontline advisers on the intersection between AI, blockchain, and IP
Sukanya Sarkar, December 07, 2023
Jiron_Darren_Large.jpg
An American abroad: 10 years of Finnegan in the UK
Darren Jiron, Finnegan’s managing partner in London, discusses the firm’s growth plans and misconceptions about US firm culture
Rory O’Neill, December 07, 2023
LMG Life Sciences Awards 2024 EMEA _ bkgrd_4x.png
LMG Life Sciences Awards EMEA 2024: open for nominations
The EMEA region research cycle has commenced - do not miss this opportunity to nominate your work from 2023!
John Harrison, December 07, 2023
goldfish jumping - improvement and career concept
Ex-Stroock partner reveals his IP aims for new role
A former partner at Stroock & Stroock & Lavan, which voted to dissolve in October, has joined McCarter & English
Rani Mehta, December 07, 2023
AI ChatGPT-comp.jpg
Weekly take: IP concern and excitement – one year of ChatGPT
As ChatGPT celebrates its first birthday, we are still grappling with a multitude of IP concerns
Max Walters, December 06, 2023
Leads.jpg
How lawyers can turn IP association roles into business leads
Sources say an official role at an IP industry body is great for generating business leads, but that shouldn’t be the only motivation behind taking on the responsibility
Sukanya Sarkar, December 06, 2023